Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
WALTHAM, Mass., April 29, 2015 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that William Heiden, AMAG's chief executive officer, and Frank Thomas, AMAG's president and...
-
WALTHAM, Mass., April 22, 2015 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced it will report unaudited consolidated financial results for the quarter ended March 31, 2015...
-
WALTHAM, Mass., April 8, 2015 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that Frank Thomas, AMAG's president and chief operating officer, will present at the 14th...
-
WALTHAM, Mass., April 1, 2015 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced new management appointments which expand the company's ability to engage with external...
-
WALTHAM, Mass., March 3, 2015 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) announced today the closing of its previously announced public offering of common stock, including the...
-
AMAG Pharmaceuticals, Inc. to Participate in the Cowen and Company 35th Annual Healthcare Conference
WALTHAM, Mass., Feb. 27, 2015 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that William Heiden, AMAG's president and chief executive officer, will present at the Cowen...
-
WALTHAM, Mass., Feb. 25, 2015 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) announced today that it has priced its previously announced underwritten public offering of common stock...
-
WALTHAM, Mass., Feb. 24, 2015 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) announced today that it has commenced an underwritten public offering of approximately $125 million of shares...
-
WALTHAM, Mass., Feb. 19, 2015 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that Frank Thomas, AMAG's executive vice president and chief operating officer, will...
-
Total fourth quarter revenue increased by 145% $73 million in pro forma fourth quarter 2014 product sales $153 million tax benefit recognized as a result of Lumara Health transaction...